rEvolutionelTerapi ApS: Financial statements 2025
CVR: 44257041
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
rEvolutionelTerapi ApS (CVR 44257041) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 231,315 and a net result of DKK 11,686 compared with DKK -15,481 the year before. That is an increase of 72.2% compared with the year before. Equity in the 2025 report amounted to DKK 36,205. The solvency ratio was 60.8%.
- Gross Profit
- DKK 231,315
- Profit/Loss
- DKK 11,686
- Equity
- DKK 36,205
- Total Assets
- DKK 59,571
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 231 t. | 12 t. | 36 t. | 0 |
| 2024 | - | 134 t. | -15 t. | 25 t. | 1 |
Official annual report
How creditworthy is rEvolutionelTerapi ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout rEvolutionelTerapi ApS
rEvolutionelTerapi ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2023. The company is registered under the industry Psykologisk og psykoterapeutisk rådgivning. The management consists of Camille Storm. The company is owned by Camille Storm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 231,315 and a net result of DKK 11,686 compared with DKK -15,481 the year before. Equity in the 2025 report amounted to DKK 36,205.